<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Sydney</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Sydney, New South Wales, Australia</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public Research University</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1850</td>
</tr>
<tr>
<td class="label">Students</td>
<td>~70,000</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://sydney.edu.au" target="_blank">https://sydney.edu.au</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Alzheimer's Disease, Parkinson's Disease, ALS, Multiple Sclerosis, Huntington's Disease, Dementia</td>
</tr>
</table>
University of Sydney
Introduction
Mermaid diagram (expand to render)
The University of Sydney (USYD) is Australia's first university, established in 1850. Located in Sydney, New South Wales, it is one of the world's leading research universities with particular strength in medicine, health sciences, and neuroscience["@university"]. The university enrolls approximately 70,000 students and employs over 8,000 academic staff, making it the largest university in Australia.
The university has been at the forefront of neurodegenerative disease research in the Asia-Pacific region. The Brain and Mind Centre brings together clinicians, researchers, and trainees to advance understanding and treatment of brain disorders including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis).
History and Development
The University of Sydney was founded in 1850 as the first university in Australia and the Southern Hemisphere. The medical school was established in 1883, and neuroscience research programs expanded significantly from the 1970s onwards.
The Brain and Mind Centre was established in 2015 as a multidisciplinary hub for neuroscience research, consolidating previously distributed research programs. The Centre brings together researchers from neurology, psychiatry, neuroscience, and engineering to address complex brain disorders.
Research Programs
Brain and Mind Centre
The University's Brain and Mind Centre is a multidisciplinary hub for neuroscience and neurological disease research[@brain]:
- Centre for Parkinson's Disease: Comprehensive research on PD diagnosis, treatment, and biomarkers including gait analysis and wearable technology
- Dementia Research Centre: Focus on Alzheimer's disease and related dementias including early detection and intervention
- Motor Neuron Disease Research: ALS and frontotemporal dementia research program with clinical trials
- Multiple Sclerosis Research: Neuroimmunology and demyelination studies
Parkinson's Disease Research
The university is a leading center for Parkinson's disease research:
- Alpha-Synuclein Studies: Investigation of protein aggregation and propagation
- LRRK2 Genetics: Studies on LRRK2 mutations in Australian populations
- Gait and Balance: Novel assessment methods using wearable sensors[@lewis2020]
- Deep Brain Stimulation: Clinical outcomes research
Alzheimer's Disease Research
Programs include:
- Biomarker Development: Blood and CSF biomarkers for early detection
- Neuroimaging: PET and MRI studies of amyloid and tau pathology
- Clinical Trials: Novel therapeutic approaches including anti-amyloid and anti-tau therapies
- Care Models: Development of integrated care models for dementia patients
Motor Neuron Disease / ALS
The university is an international leader in ALS research:
- Genetic Studies: Identification of new genetic risk factors including C9orf72[@kiernan2021]
- Biomarkers: Neurofilament-based biomarkers for disease monitoring
- Clinical Trials: Phase I-III trials of novel therapeutic agents
- Clinical Care: Multidisciplinary ALS clinic at Royal Prince Alfred Hospital
Key Research Themes
| Disease Area | Research Focus | Key Researchers |
|-------------|----------------|------------------|
| Parkinson's Disease | Alpha-synuclein, LRRK2, gait analysis | Prof. Simon J. G. Lewis |
| Alzheimer's Disease | Biomarkers, neuroimaging, clinical trials | Prof. Karen L. M. S. |
| ALS | Genetic factors, biomarkers | Prof. Matthew C. Kiernan |
| Multiple Sclerosis | Neuroprotection, remyelination | Prof. Michael H. Barnett |
| Huntington's Disease | Genetic therapies, biomarker development | Prof. Clement J. L. Loy |
Notable Researchers
| Researcher | Position | Focus Areas | H-index |
|------------|----------|-------------|---------|
| Prof. Simon J. G. Lewis | Parkinson's Research Lead | Movement disorders, gait analysis | 80 |
| Prof. Matthew C. Kiernan | ALS Program Director | Motor neuron disease, biomarkers | 100 |
| Prof. Michael H. Barnett | MS Research Lead | Neuroimmunology, demyelination | 70 |
| Prof. Ian P. Hickie | Brain and Mind Centre Director | Depression, neuropsychiatry | 75 |
Clinical Services
The university provides clinical services through affiliated hospitals:
- Royal Prince Alfred Hospital: ALS clinic and general neurology
- Sydney Adventist Hospital: Memory disorders and dementia care
- Westmead Hospital: Movement disorders and Parkinson's disease
Training Programs
The University of Sydney offers extensive training in neuroscience and neurodegeneration:
- Sydney Neuroscience Academy: Professional development for clinicians and researchers
- PhD Program in Neuroscience: Comprehensive training through the Brain and Mind Centre
- Medical Research Training Scheme: Clinician-scientist training in neurodegeneration
Major Discoveries and Contributions
Parkinson's Disease Progression Markers: Development of novel biomarkers for PD progression
ALS Genetic Studies: Identification of new genetic risk factors for ALS
Multiple Sclerosis Treatments: Clinical trials for novel neuroprotective therapies
Dementia Care Models: Development of integrated care models for dementia patients
International Collaborations
USYD maintains active collaborations with:
- Macquarie University: Joint research programs in neuroscience
- University of Melbourne: Australian neurodegeneration research network
- King's College London: International collaboration on Parkinson's disease
- UCL: Alzheimer's disease research partnership
- US institutions: Harvard, Stanford collaborations
- European research consortia: EU JPND participation
External Links
- Official Website: [University of Sydney](https://sydney.edu.au)
- Brain and Mind Centre: [Brain and Mind Centre](https://sydney.edu.au/brain-mind)
- Dementia Research: [Sydney Dementia Research](https://sydney.edu.au/dementia)
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Huntington's Disease](/diseases/huntingtons)
- [Alpha-Synuclein](/proteins/alpha-synuclein)
- [LRRK2](/genes/lrrk2)
- [University of Melbourne](/institutions/university-of-melbourne)
- [Macquarie University](/institutions/macquarie-university)
References
University of Sydney. Official Website, https://sydney.edu.au (n.d.)
Brain and Mind Centre. Research Programs, https://sydney.edu.au/brain-mind (n.d.)
Lewis et al, Parkinson's disease: biomarkers and treatment (2020)
Kiernan et al, Amyotrophic lateral sclerosis (2021)